Ludwig from Denmark

Registered at the short selling broker eToro, 3 minutes ago.

» Try eToro you too
67% of retail investor accounts lose money when trading CFDs with etoro.
Don't show again

Eli Lilly & Co. (LLY) shares information

Lilly(Eli) & Co


24h Change

0.15 %

LLY

Live rate: Market closed

Stock data per Friday 1 Jul, 2022

LLY
NEW YORK STOCK EXCHANGE INC.
324.23
323.68
324.71
0.48 (+ 0.15%)
US Market is closed

Live Stock price in graph for Lilly(Eli) & Co (LLY)

  • Latest Volume

    1,817,810 (-33.48 %)

  • Volume prev. day

    2,732,891

  • Avg. daily volume

    3,207,703

  • Market cap

    308,526,310,403

  • P/E ratio

    48.25

  • Today high

    325.4 USD

  • Today low

    317.76 USD

  • 52 week high

    330.85 USD

  • 52 week low

    217.84 USD

  • YTD Change

    + 18.59 %

Quick links

 

Latest news about Lilly(Eli) & Co

Below you can find the most recent news posts about Lilly(Eli) & Co, primarily from US and UK based news sources.

As amyloid-targeting therapies for Alzheimer”s fail, where might success lie? (NYSE:LLY)

Saturday, 2 July 2022, 20:00:00
Mid- and late-stage data readouts over the last few years for Alzheimers therapies have had a similar theme: Failure.
— Seeking Alpha


If You Invested $100 In This Stock 5 Years Ago, You Would Have $400 Today

Wednesday, 29 June 2022, 23:53:12
Eli Lilly (NYSE: LLY ) has outperformed the market over the past 5 years by 21.93% on an annualized basis producing an average annual return of 31.32%. Currently, Eli Lilly has a market capitalization of $307.03 billion. Buying $100 In LLY: If … Full story available on Benzinga.com
— Benzinga


The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data

Wednesday, 29 June 2022, 18:06:23
Here”s a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eli Lilly To Supply Additional 150K Doses Of COVID-19 Treatment To US Government Eli Lilly And Co (NYSE: LLY ) has announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately $275 million . The existing U.S. government supply of bebtelovimab, including the new purchase, is expected to meet present demand through late August 2022. Bebtelovimab continues to maintain neutralization activity against the omicron variants. An option for an additional 350,000 doses to be exercised no later than Sept. 14 will remain in the agreement. 89bio Posts Promising Pegozafermin Data For Severe Hypertriglyceridemia 89bio Inc (NASDAQ: ETNB ) announced topline results from the ENTRIGUE Phase 2 proof-of-concept study of pegozafermin for severe hypertriglyceridemia (SHTG). Treatment with pegozafermin resulted in clinically meaningful and significant reductions in TG from baseline across all doses (with a 63% reduction in the highest dosing group).
— Benzinga


5 S&P 500 Stocks Ready to Break Out

Wednesday, 29 June 2022, 17:50:08
These S&P 500 stocks are primed to blast through resistance, meaning massive gains for investors. Alphabet ( GOOGL , GOOG ): Anticipation of July’s 20-for-1 stock split should drive this tech titan back into an uptrend. Eli Lilly ( LLY ): Shares are up 17% this year, trouncing the S&P 500. Bristol Myers Squibb ( BMY ): Forget waiting, this stock just blasted a six-year resistance level, jumping to a new record. International Business Machine ( IBM ): Relative strength has this sleepy dividend stock on the brink of breaking through three-year resistance. Domino’s Pizza ( DPZ ): A freshly completed bottoming pattern will send shares of this pizza chain through $400. Last week’s rally ushered many S&P 500 stocks into critical resistance levels, and some even mustered the strength to blast through them. In scanning the large-capitalization stocks of the land, I found five that deserve special attention. And their relative strength suggests more upside to come. Trading around support or resistance thresholds allows traders to play when the odds are in their favor and when there’s an asymmetric payout.
— InvestorPlace


Lilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment Options

Wednesday, 29 June 2022, 17:04:00
VANCOUVER, British Columbia–(BUSINESS WIRE)—- $ABCL #AbCellera–AbCellera (Nasdaq: ABCL) today announced that Eli Lilly and Company (Lilly) has entered into a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab, the second antibody developed through AbCellera’s collaboration with Lilly, for approximately $275 million. The existing U.S. government supply of bebtelovimab, including the new purchase, is expected to meet present demand through late August 2022.
— Business Wire


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have LLY available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.